Barry S Shea MD
Critical Care Medicine, Interstitial Lung Diseases
Assistant Professor of Medicine
Join to View Full Profile
55 Fruit StreetBulfinch 148Boston, MA 02114
Phone+1 617-726-1721
Fax+1 617-724-9948
Dr. Shea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Barry Shea, MD, is a pulmonologist based in Boston, MA, with subspecialties in critical care medicine and interstitial lung diseases. He pursued his education from Tufts University School of Medicine, followed by residency in internal medicine at New York Presbyterian Hospital and a fellowship in pulmonary disease and critical care medicine at Massachusetts General Hospital/BIDMC/Harvard Medical School. He is currently affiliated with Massachusetts General Hospital as an associate physician and assistant professor of medicine. As an expert in pulmonary fibrosis, interstitial lung disease, and critical care medicine, Dr. Shea has contributed to numerous medical publications, continuously adding to his expertise.
Education & Training
Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2009
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2000 - 2003
Tufts University School of MedicineClass of 2000
Certifications & Licensure
MA State Medical License 2005 - 2026
RI State Medical License 2014 - 2026
NY State Medical License 2002 - 2005
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Anti-Ro52 Seropositive Interstitial Lung Disease Is Associated With a Higher Risk of Disease Progression and Mortality.Ryosuke Imai, Rene S Bermea, Sophia H Zhao, Sydney B Montesi, Anjali Singh
Chest. 2025-06-06 - Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD.Bess M Flashner, Ryosuke Imai, Andrew J Synn, Julia K Munchel, Lida P Hariri
Respiratory Medicine and Research. 2025-05-13 - Progressive course of anti-nuclear matrix protein-2 (NXP-2) positive-interstitial lung disease.Bess M Flashner, Ryosuke Imai, Andrew J Synn, Julia K Munchel, Lida P Hariri
Respiratory Medicine and Research. 2025-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
